The world of DNA testing is changing fast and the race is on to provide cheap, quick genetic diagnoses for patients. Symon Cotton, Head of Life Sciences takes a look at the opportunities on offer for companies working in this ...

Cell4D is developing ‘fingerprinting’ technology for live cells using mechanomics, a discipline sitting at the intersection of biology and biomechanics. This biomarker that is used to screen and sort live cells for cell therapies ...

グローバル製薬企業は成功と失敗の大きな分かれ道に差し掛かっています。このような状況下では、業界が一丸となって新技術のもたらす一世一代のチャンスを掴むことが欠かせません。

Founders of early-stage start-ups are passionate, driven and optimistic. So, as they embark on the mission to sell their vision, they should accentuate the positive and keep negative thoughts of risk to the back of their mind, right? Wrong ...

AI-based methods are offering superhuman image enhancement. But their medical applications are not without risk – unless, that is, you consider a hybrid approach… ...

This whitepaper describes the benefits of introducing advanced wireless capabilities into surgical and critical care settings, the technical approaches to achieve this, and the challenges that can arise. It concludes with our vision for some exemplar use cases.  ...

The future promises a digitally connected healthcare system that empowers both patients and carers alike. So, what’s the next step for pharma companies and device developers with ambitions in the space? ...

この度のケンブリッジコンサルタンツのブランドリニューアルにより、The Engineとの関係がより強固になりました。The Engineは、MIT（マサチューセッツ工科大学）によって設立されたベンチャーキャピタルであり、気候変動、健康といった長期での社会的課題解決を目指すアーリーステージの「タフテック」企業を支援しています。戦略的パートナーとして、士気が高く、使命感に溢れているスタートアップの起業家と関わることは、弊社にとって大きな喜びです。

The ability to count and track individual units of light can have an exciting range of applications across medtech and beyond, as a recent collaboration with Cambridge University has proved ...